1. Home
  2. ZLAB vs BNL Comparison

ZLAB vs BNL Comparison

Compare ZLAB & BNL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ZLAB
  • BNL
  • Stock Information
  • Founded
  • ZLAB 2013
  • BNL 2007
  • Country
  • ZLAB China
  • BNL United States
  • Employees
  • ZLAB N/A
  • BNL N/A
  • Industry
  • ZLAB Biotechnology: Pharmaceutical Preparations
  • BNL Real Estate Investment Trusts
  • Sector
  • ZLAB Health Care
  • BNL Real Estate
  • Exchange
  • ZLAB Nasdaq
  • BNL Nasdaq
  • Market Cap
  • ZLAB 3.6B
  • BNL 3.5B
  • IPO Year
  • ZLAB 2017
  • BNL 2020
  • Fundamental
  • Price
  • ZLAB $32.91
  • BNL $18.48
  • Analyst Decision
  • ZLAB Buy
  • BNL Buy
  • Analyst Count
  • ZLAB 6
  • BNL 7
  • Target Price
  • ZLAB $57.22
  • BNL $19.71
  • AVG Volume (30 Days)
  • ZLAB 725.2K
  • BNL 1.6M
  • Earning Date
  • ZLAB 11-11-2025
  • BNL 10-29-2025
  • Dividend Yield
  • ZLAB N/A
  • BNL 6.26%
  • EPS Growth
  • ZLAB N/A
  • BNL N/A
  • EPS
  • ZLAB N/A
  • BNL 0.52
  • Revenue
  • ZLAB $427,799,000.00
  • BNL $442,203,000.00
  • Revenue This Year
  • ZLAB $41.60
  • BNL $4.91
  • Revenue Next Year
  • ZLAB $53.42
  • BNL $5.98
  • P/E Ratio
  • ZLAB N/A
  • BNL $35.72
  • Revenue Growth
  • ZLAB 32.56
  • BNL 3.85
  • 52 Week Low
  • ZLAB $23.70
  • BNL $13.96
  • 52 Week High
  • ZLAB $44.34
  • BNL $18.86
  • Technical
  • Relative Strength Index (RSI)
  • ZLAB 49.59
  • BNL 58.10
  • Support Level
  • ZLAB $33.76
  • BNL $17.53
  • Resistance Level
  • ZLAB $34.72
  • BNL $18.75
  • Average True Range (ATR)
  • ZLAB 0.86
  • BNL 0.29
  • MACD
  • ZLAB 0.20
  • BNL -0.01
  • Stochastic Oscillator
  • ZLAB 51.19
  • BNL 81.56

About ZLAB Zai Lab Limited

Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.

About BNL Broadstone Net Lease Inc.

Broadstone Net Lease Inc is an internally managed real estate investment trust that invests in, owns, and manages single-tenant commercial real estate properties that are net leased on a long-term basis to a diversified group of tenants. The company has selectively invested in net leased assets in the industrial, healthcare, restaurant, retail, and office property types. The company focuses on investing in real estate that is operated by creditworthy single tenants in industries characterized by positive business drivers and trends. The company targets properties that are an integral part of the tenants' businesses and are therefore opportunities to secure long-term net leases.

Share on Social Networks: